Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch
Ms. Chloe CARPENTIER, Chief, UNODC Drug Research Section
Ms. Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Ms. Fariba SOLTANI, Chief, UNODC HIV/AIDS Section & Global Coordinator for HIV/AIDS
Mr. Troy Jack Thevathasan, Deputy Director (Correctional Rehabilitation Services), Singapore Prison Service
Mr. Christopher M. Jones, PharmD, DrPH, MPH; CAPT, US Public Health Service; Deputy Director’ National Center for Injury Prevention and Control; Centers for Disease; Control and Prevention
Mr. Evgeny Bryun, Head of the Moscow Research and Practice Centre for Drug Addiction, Russian Federation
Dr. Tlaleng MOFOKENG (Ms.), UN Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of health
Vladimir Poznyak, Coordinator, Coordinator, Alcohol, Drugs and Addictive Behaviours, [video message]
Prof. Jallal Toufiq, Board Member, International Narcotics Control Board
Annette Verster, Technical Officer, Global HIV, Hepatitis and Sexually Transmitted Infections Programmes
Dr. Zukiswa ZINGELA, Board Member, International Narcotics Control Boar
Mr Ninan Varughese, Director a.i. of the Joint United Nations Programme on HIV and AIDS (UNAIDS) New York Office
Ms Jane Mounteney, Head of the Public Health Unit, European Monitoring Centre for Drugs and Drug Addiction
Mr. Phaedon KALOTERAKIS, World Federation for Therapeutic Communities, Greece
Ms. Colleen DANIELS, Harm Reduction International, United Kingdom, [statement]
Ms. Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Mr. Zaved Mahmood, Human Rights and Policy Advisor, Office of the High Commissioner for Human Rights
Dr. Massimo Barra, Vice-President IFCR
Ms. Stacey DOORLY-JONES, STAND – Social Transformation Action Defined, South Africa
Mr. Sharif MOHR, Drug Free America Foundation, United States, [video message]
Ms. Kathleen GANNON, Karim Khan Afridi Welfare Foundation, Pakistan, [video message]
Mr. Stelio CRAVEIRINHA, Mozambican Network of People who Use Drugs, Mozambique, [video message]
Ms. Laurene COLLARD, Civil Society Forum on Drugs, European Union, [video message]
Ms. Maria Angélica DE CASTRO COMIS, Centro de Convivência É de Lei, Brazil, [video message]
Ms. Angela Me, Chief, UNODC Research and Trend Analysis Branch
Mr. Justice Tettey, Chief, UNODC Laboratory and Scientific Section
Dr. Owen Bowden-Jones, Chair of the UK Advisory Council on the Misuse of Drugs, O'Malley Kieran (Home Office Science)
Ms. Amrita DEVI, Director for Strengthening Community Based Rehabilitation Institutions, the Indonesian National Narcotics Board
Dr. Gady Zabicky Sirot, Comisionado Nacional contra las Adicciones de la Secretaría de Salud, Mexico, (National Commissioner Against Addictions of the Ministry of Health, Mexico
H.E. Ambassador David JOHNSON, Board Member, International Narcotics Control Board
Dilkushi Poovendran, Technical Officer, Expert Committee on Drug Dependence
H.E. Mr. Adam NAMM, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD) of the Organization of American States (OAS)
Mr. Shane VARCOE, Dalgarno Institute, Australia, [video message]
Mr. Wei HAO, Professor of Psychiatry, Second Xiangya Hospital, Central South University
Dr. Antonio Pascale, Director of the Toxicology and Problematic Drug Use Service of the Ministry of the Interior
Stefanie Caroline Schmatz, Associate Drug Control and Crime Prevention Officer, UNODC Laboratory and Scientific Section
Giovanna CAMPELLO, UNODC Prevention, Treatment and Rehabilitation Section
Monica Ciupagea, Expert, UNODC HIV/AIDS Section
Ms. Eliza Kurcevič, Eurasian Harm Reduction Association (EHRA), Lithuania
Prof. Dr. Munir MOOSA, Global Forum for Teachers Educators, Pakistan
Ms. Nazlee MAGHSOUDI, Centre on Drug Policy Evaluation (CDPE), Canada
Mr. Mauro Adrián DÍAZ MORENO, Corporación Acción Técnica Social, Colombia, [video message]
Ms. Chloé CARPENTIER, Chief, UNODC Drug Research Section
Ms. Elizabeth MATTFELD, UNODC Prevention, Treatment and Rehabilitation Unit, Drug Prevention and Health Branch
Dr. Musa UMAR, Director, (Narcotics and Controlled Substances), National Agency for Food, Drug Administration and Control (NAFDAC)
Mr. Atul AMBEKAR, M.D. Professor, National Drug Dependence Treatment Centre and Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India
Dr. Tammam Aloudat, Deputy Executive Director, Médecins Sans Frontières (MSF) Access Campaign
Dra. Adriana Templos, Head of the Palliative Care Division of the General Hospital Dr. Manuel Gea González
Dr. Galina KORCHAGINA, Board Member, International Narcotics Control Board, Bulgaria
Gilles Forte, Coordinator, Access to Medicines and Health Products
Mr Alfredo POLO, Radiation Oncologist, IAEA Applied Radiation Biology and Radiotherapy Section
Ms. Marta Ximena León, Universidad de La Sabana, Colombia, [video message]
Ms. Raffaella RAVINETTO, Institute of Tropical Medicine, Antwerp, Belgium
Stefanie Caroline Schmatz
Prof. David Nutt, Drug Science, United Kingdom
Ms. Diana NEVZOROVA, Hospice Care Professionals Association, Russian Federation, [video message]
Mr. Bishnu Fueal SHARMA, Recovering Nepal, National Federation of PUD and Drug services Organizations, Nepal, [video message]
Mr. Mark Donald BIKOSA MWES, Palliative Care Association of Uganda (PCAU), Uganda, [video message]
Dr. Katherine Pettus, Advocacy Officer, the International Association for Hospice and Palliative Care (IAHPC) & Ms. Kate Reed, Advocacy Focal Point IAHPC, National Clinical Advisor of Palliative Care Australia (PCA) (written submission)
David Oliver, The European Association for Palliative Care, PhD, FRCP, FCRGP, FEAN, Honorary Professor University of Kent, Canterbury, UK, Retired Consultant in Palliative Medicine at Wisdom Hospice, Rochester, UK, Member of European Union Civil Society Forum on Drugs (written submission)
Lauren Deluca, the Founding President and Executive Director of Chronic Illness Advocacy & Awareness Group (CIAAG) (written submission)
